 Respiratory tract infections, RTIs, are a major cause of morbidity and mortality worldwide, with the majority of cases being treated in primary care settings. In order to optimize patient care and reduce the risk of antimicrobial resistance, it is essential to rapidly identify the causative agent and accurately assess the severity of the disease. Recent advancements in diagnostic technology have enabled rapid identification of pathogens and improved monitoring of disease progression, allowing for more accurate and efficient management of RTI patients. These advancements include the use of genomic sequencing, digital transformation and the development of novel diagnostic tools such as point of care tests and biomarker assays. By leveraging these new technologies, clinicians can now make informed decisions about the best course of action for each individual patient. This article was authored by Zoran Stiyanovich, Felipe Goncalves-Carvalho, Alicia Mourine and others. We are article.tv, links in the description below.